{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fthebrief-health.simplecast.com%2Fepisodes%2Fnew-hope-for-liver-fibrosis-treatment-2vxE41bI","width":444,"version":"1.0","type":"rich","title":"New Hope for Liver Fibrosis Treatment","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/90af2279-f7d9-426f-bdb6-cb4a4a221358/e73b2da8-efa4-49ef-98e2-a9f59a227a12/thebriefhealth-square-logo-white-background.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/58418377-bca9-41d6-8484-cee90da9a2b8\" height=\"200\" width=\"100%\" title=\"New Hope for Liver Fibrosis Treatment\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"McMaster researchers report EVT0185 may prevent and reverse liver fibrosis by targeting metabolism, offering a promising therapy for MASH with clinical trials expected by 2027."}